View Older Stories View More Recent Stories

Oct 17, 2014 12:59PM Celator Pharmaceuticals (CPXX) Plans Common Stock, Warrants Offering

Oct 17, 2014 12:57PM Celator(R) Pharmaceuticals Announces Public Offering of Common Stock and Warrants to Purchase Common Stock

Oct 17, 2014 09:24AM Roth Boosts PT on Pharmacyclics (PCYC) to $188; Imbruvica Continues to Gain Traction

Oct 17, 2014 09:01AM Roth Capital Remains Positive on Regeneron (REGN); Latest Outcome Better Positions Eylea as Superior DME Treatment

Oct 16, 2014 02:22PM Roth Capital Positive on Curis (CRIS) Following Q3 Results from Roche/Erivedge

Oct 16, 2014 07:53AM Roth Capital Adds MEI Pharma (MEIP) to Focus List; Multiple Key Inflection Points Coming

Oct 15, 2014 06:54AM Roth Capital Downgrades Durata Therapeutics (DRTX) to Neutral

Oct 14, 2014 07:20AM Roth Capital Starts The Hackett Group (HCKT) at Buy

Oct 13, 2014 11:52AM New Pharmacyclics (PCYC) Collaboration Further Validates Imbruvica; Roth Boosts PT to $185

Oct 13, 2014 09:26AM Roth Sees Visibility in Cytokinetics' (CYTK) CK-107 Program Increasing Significantly Moving Forward

Oct 13, 2014 08:41AM NCE Status Won't Matter for Keryx Biopharma (KERX) - Roth Capital

Oct 10, 2014 04:11PM Cytori Therapeutics (CYTX) Closes on $13.5M in Financing

Oct 10, 2014 10:55AM Notable Analyst Rating Changes 10/10: (IPXL) (EA) (AON) Upgraded; (JCP) (GRPN) (BDSI) Downgraded

Oct 10, 2014 07:10AM Roth Capital Resumes XOMA, Ltd. (XOMA) at Buy

Oct 10, 2014 06:36AM Roth Capital Downgrades BioDelivery Sciences International (BDSI) to Neutral

Oct 9, 2014 05:30PM ARI Network Services, Inc. Announces the Appointment of Chad J. Cooper to Board of Directors

Oct 9, 2014 11:50AM Roth Positive on SolarCity's (SCTY) Loan Program; Sees Tail Risks Ebbing

Oct 9, 2014 06:36AM Roth Capital Upgrades Golden Minerals Company (AUMN) to Buy

Oct 8, 2014 11:33AM PlacementTracker Publishes Third Quarter 2014 PIPE Market League Tables

Oct 8, 2014 08:06AM Cytori Therapeutics (CYTX) Announces $13.5M Registered Direct Placement

Oct 7, 2014 12:23PM Roth Capital Cuts SodaStream International (SODA) to Neutral

Oct 7, 2014 10:56AM Notable Analyst Rating Changes 10/7: (IR) (ADHD) (AAPL) Upgraded; (SNSS) (DE) (CBSH) Downgraded

Oct 7, 2014 07:49AM Roth Keeps Regeneron (REGN) at 'Buy'; Another Eylea Approval is No Surprise

Oct 7, 2014 07:13AM Roth Capital Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Neutral

Oct 6, 2014 04:40PM Trina Solar (TSL) Closes 10.3M ADS, $115M Conv. Notes Offerings

Oct 6, 2014 09:43AM Roth Capital Affirms SolarCity (SCTY) at 'Buy'; Comments on Recent Meetings with Management

Oct 6, 2014 06:30AM Roth Capital Starts ContraFect Corp. (CFRX) at Buy; Market Missing Potential Impact of Bacteriophage Lysins

Oct 2, 2014 09:39AM Recent Moves by Curis (CRIS) May Increase Value of CUDC-907 - Roth Capital

Oct 1, 2014 09:11AM Trina Solar (TSL) Prices 10.3M ADS, $100M Conv. Notes Offering

Oct 1, 2014 07:50AM Lerge Commercial Exit by RGS Energy (RGSE) is 'Right Move' - Roth

Sep 30, 2014 10:44AM Latest Data for Regeneron's (REGN) Dupilumab Broadens Benefit Profile - Roth

Sep 29, 2014 01:49PM Roth Lowers Ests on Galena Biopharma (GALE) Following Special Committee Report

Sep 29, 2014 12:04PM Streetinsider.com's Hot Lunchtime Reads 9/29: (AAPL) (JACK) (BLRXX) (TSLA)

Sep 29, 2014 11:27AM Daiichi Sankyo, Ambit (AMBI) Deal is Positive for BioLineRx (BLRX) - Roth Capital

Sep 29, 2014 09:52AM Roth Maintains Keryx Biopharma (KERX) at Buy Following Initiation of Ferric Citrate Phase 2

Sep 29, 2014 06:51AM Roth Capital Starts Super Micro Computer (SMCI) at Buy

Sep 26, 2014 12:44PM Roth Capital Downgrades AcelRx Pharmaceuticals (ACRX) to Neutral

Sep 24, 2014 10:57AM Roth 'Encouraged' by Rexahn's (RNN) RX-3117 Receiving FDA Orphan Drug Designation; Offers Commentary

Sep 24, 2014 09:53AM Roth Comments on ImmunoCellular's (IMUC) Licensing Agreement with Caltech; Affirms at 'Buy'

Sep 24, 2014 06:35AM Roth Positive on SolarCity (SCTY) Following Closure of Silevo Deal; Affirms 'Buy' Rating

Sep 23, 2014 11:47AM Roth Comments on TG Therapeutics' (TGTX) TGR-1202 Licensing Announcement

Sep 23, 2014 06:45AM Roth Capital Downgrades Concur Technologies (CNQR) to Neutral

Sep 22, 2014 06:49AM Roth Capital Starts Bluebird Bio (BLUE) at Buy

Sep 19, 2014 10:57AM Sky Solar Holdings, Ltd. (SKYS) Files $100M IPO

Sep 19, 2014 07:10AM Roth Capital Starts Ideal Power (IPWR) at Buy

Sep 19, 2014 06:45AM Roth Capital Starts CymaBay Therapeutic (CBAY) at Buy

Sep 18, 2014 10:37AM Roth 'Encouraged' by Spectrum's (SPPI) Licensing Agreement with CASI Pharma (CASI)

Sep 17, 2014 12:16PM Streetinsider.com's Hot Lunchtime Reads 9/17: (ATVI) (NKE) (AAPL) (BLRX)

Sep 17, 2014 11:25AM Preclinical BioLineRx (BLRX) BL-8040 Data on AML is Encouraging - Roth Capital

Sep 17, 2014 09:30AM Roth Comments on Concert's (CNCE) Initiation of CTP-730 Phase 1

View More Recent Stories View Older Stories